Claney Lebev Pereira

This inventor holds 13 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 10 EPO patents. Top assignees: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Idorsia Pharmaceuticals Ltd, Vaxxilon Ag. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claney Lebev Pereira. Retrieved from https://idiyas.com/inventor/claney-lebev-pereira

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 3)

% Patents Active = 92.3

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 10 (Patent Applications = 20)

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 23(Granted Patents)

Company Filing History:

9 out of 1,334

Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V.

patents

4 out of 81

Idorsia Pharmaceuticals Ltd

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12187756 - Stable vaccine against (2025-01-07),

2. 12043643 - Vaccine against klebsiella pneumoniae (2024-07-23),

3. 11891413 - Vaccine against (2024-02-06),

4. 11479574 - Vaccine against (2022-10-25),

5. 11191822 - Pneumococcal polysaccharide-protein conjugate composition (2021-12-07),

6. 11014952 - Stable hydrolysis-resistant synthetic polyribosylribitolphosphate derivatives as vaccines againsttype b (2021-05-25),

7. 10864261 - Synthetic vaccines againstserotype 2 (2020-12-15),

8. 10688169 - Vaccines against carbapenem-resistant (2020-06-23),

9. 10596272 - Vaccines againstserotype 5 (2020-03-24),

10. 10328141 - [object Object] (2019-06-25),

11. 10220083 - [object Object] (2019-03-05),

12. 10188718 - [object Object] (2019-01-29),

13. 10052373 - [object Object] (2018-08-21),

Title: Claney Lebev Pereira: Pioneering Innovator Shaping the Future of Healthcare

Introduction: Claney Lebev Pereira, a distinguished inventor based in Berlin, DE, is known for his exceptional passion for innovation and his unwavering commitment to excellence. With a remarkable portfolio of 11 patents, Pereira continues to inspire the next generation of inventors and drive advancements in technology and beyond.

Latest Patents: Pereira's recent patents showcase his groundbreaking work in the field of healthcare. His inventions include a vaccine against serotype O3, O3, and O5 lipopolysaccharide, as well as a synthetic saccharide related to serotype O1, O2, O2ac, and O8 O-polysaccharide. These pharmaceutical compositions play a crucial role in preventing and treating diseases associated with specific bacteria strains, highlighting Pereira's significant contributions to the medical industry.

Career Highlights: Throughout his illustrious career, Pereira has collaborated with renowned organizations such as Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. and Idorsia Pharmaceuticals Ltd. His innovative spirit and dedication to scientific progress have led to the development of revolutionary solutions that have the potential to transform healthcare practices globally.

Collaborations: Pereira has had the privilege of working alongside esteemed colleagues, including Peter H. Seeberger and Chakkumkal Anish. These collaborative efforts have fostered a dynamic environment of creativity and ingenuity, resulting in pioneering advancements in the field of biomedical research.

Conclusion: Claney Lebev Pereira's trailblazing inventions and relentless pursuit of excellence underscore his profound impact on the future of technology and healthcare. His innovative mindset and visionary approach continue to shape industry standards, paving the way for a brighter and healthier tomorrow.

Profile summary based on public USPTO records.